Cencora, Inc.
323.32USD
-1.3700 (-0.42%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.56▼ | $4.58 | 1 | 8 |
| Next quarter | $4.61▲ | $4.5 | 3 | 2 |
| Current year | $17.87▲ | $17.75 | 10 | 0 |
| Next year | $19.78▲ | $19.76 | 3 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.35 | $4.48 | +0.13 (+3.0%) |
| 2026-03-31 | $4.72 | $4.75 | +0.03 (+0.7%) |
| 2025-12-31 | $4.04 | $4.08 | +0.04 (+1.0%) |
| 2025-09-30 | $3.79 | $3.84 | +0.05 (+1.4%) |
61 ratings from 15 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Reiterated | Sector Perform | $330 | Sep 8, 2026 |
| RBC Capital | Initiated | Sector Perform | $330 | Aug 19, 2026 |
| Wells Fargo | Maintained | Overweight | $331 $395 | Aug 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $342 $346 | Aug 7, 2026 |
| JP Morgan | Maintained | Overweight | $382 $390 | Aug 7, 2026 |
| UBS | Maintained | Buy | $412 $430 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $330 $350 | Aug 6, 2026 |
| B of A Securities | Maintained | Neutral | $280 $285 | Jun 24, 2026 |
| Barclays | Maintained | Overweight | $425 $350 | Jun 10, 2026 |
| Wells Fargo | Maintained | Overweight | $429 $331 | May 11, 2026 |
| UBS | Maintained | Buy | $410 $412 | May 7, 2026 |
| Citigroup | Maintained | Buy | $405 $355 | May 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $360 $300 | May 7, 2026 |
| Baird | Maintained | Outperform | $420 $339 | May 7, 2026 |
| William Blair | Initiated | Market Perform | — | Apr 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $420 $360 | Apr 8, 2026 |
| Barclays | Maintained | Overweight | $400 $425 | Feb 13, 2026 |
| JP Morgan | Maintained | Overweight | $417 $419 | Feb 10, 2026 |
| Wells Fargo | Maintained | Overweight | $405 $429 | Feb 10, 2026 |
| Evercore ISI Group | Maintained | Outperform | $440 $420 | Feb 5, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $361 $400 | Jan 29, 2026 |
| Jefferies | Upgraded from Hold | Buy | $330 $440 | Jan 22, 2026 |
| B of A Securities | Maintained | Neutral | $380 $360 | Jan 5, 2026 |
| Barclays | Initiated | Overweight | $400 | Dec 9, 2025 |
| JP Morgan | Maintained | Overweight | $344 $417 | Nov 11, 2025 |
153 filings from 19 insiders · 21 buy / 2 sell over 6m
Officers and directors of COR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Krikorian LazarusOfficer, SVP & Chief Accounting Officer | Sell | 985 | $325.97 | $321k | Sep 1, 2026 |
| CAMPBELL ELIZABETH SOfficer | Sell | 11.3k | $324.12 | $3.66M | Aug 24, 2026 |
| NALLY DENNIS MDirector | Grant | 113 | $311.34 | $35k | Jul 31, 2026 |
| TYLER LAUREN M.Director | Grant | 97 | $311.34 | $30k | Jul 31, 2026 |
| COOPER ELLENDirector | Grant | 97 | $311.34 | $30k | Jul 31, 2026 |
| BATTAGLIA SILVANAOfficer | Grant | 58 | $240.53 | $14k | Jun 30, 2026 |
| CAMPBELL ELIZABETH SOfficer | Grant | 49 | $240.53 | $12k | Jun 30, 2026 |
| TYLER LAUREN M.Director | Buy | 550 | $270.23 | $149k | Jun 22, 2026 |
| DURCAN DERMOT MARKDirector | Buy | 4.0k | $274.19 | $1.10M | Jun 18, 2026 |
| DURCAN DERMOT MARKDirector | Buy | 4.0k | $266.26 | $1.07M | May 28, 2026 |
| NALLY DENNIS MDirector | Grant | 116 | $304.00 | $35k | May 1, 2026 |
| TYLER LAUREN M.Director | Grant | 99 | $304.00 | $30k | May 1, 2026 |
| COOPER ELLENDirector | Grant | 99 | $304.00 | $30k | May 1, 2026 |
| CLEARY JAMES F. JR.Chief Financial Officer | Other | 12.6k | — | — | Mar 11, 2026 |
| CAMPBELL ELIZABETH SOfficer | Other | 12.6k | — | — | Mar 11, 2026 |
| BATTAGLIA SILVANAOfficer | Other | 8.4k | — | — | Mar 11, 2026 |
| NALLY DENNIS MDirector | Grant | 655 | $359.22 | $235k | Mar 5, 2026 |
| CLYBURN FRANKLIN KING JR.Director | Grant | 557 | $359.28 | $200k | Mar 5, 2026 |
| MILLER REDONDA M.D.Director | Grant | 557 | $359.28 | $200k | Mar 5, 2026 |
| TYLER LAUREN M.Director | Grant | 641 | $359.22 | $230k | Mar 5, 2026 |
No analyst notes on COR yet.
Analyst Ratings
13 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 8 | 4 | 0 | 0 | Buy2.07 |
| 1 mo ago | 4 | 8 | 3 | 0 | 0 | Buy1.93 |
| 2 mo ago | 4 | 8 | 2 | 0 | 0 | Buy1.86 |
| 3 mo ago | 4 | 8 | 2 | 0 | 0 | Buy1.86 |